These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34419687)

  • 21. FGF-21 and GDF-15 are increased in migraine and associated with the severity of migraine-related disability.
    He J; Zhou M; Zhao F; Cheng H; Huang H; Xu X; Han J; Hong W; Wang F; Xiao Y; Xia J; Liu K
    J Headache Pain; 2023 Mar; 24(1):28. PubMed ID: 36935492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease.
    Davis RL; Liang C; Edema-Hildebrand F; Riley C; Needham M; Sue CM
    Neurology; 2013 Nov; 81(21):1819-26. PubMed ID: 24142477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
    Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
    Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy.
    Poulsen NS; Madsen KL; Hornsyld TM; Eisum AV; Fornander F; Buch AE; Stemmerik MG; Ruiz-Ruiz C; Krag TO; Vissing J
    Mitochondrion; 2020 Jan; 50():35-41. PubMed ID: 31669236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases.
    Matsuhashi T; Sato T; Kanno SI; Suzuki T; Matsuo A; Oba Y; Kikusato M; Ogasawara E; Kudo T; Suzuki K; Ohara O; Shimbo H; Nanto F; Yamaguchi H; Saigusa D; Mukaiyama Y; Watabe A; Kikuchi K; Shima H; Mishima E; Akiyama Y; Oikawa Y; Hsin-Jung HO; Akiyama Y; Suzuki C; Uematsu M; Ogata M; Kumagai N; Toyomizu M; Hozawa A; Mano N; Owada Y; Aiba S; Yanagisawa T; Tomioka Y; Kure S; Ito S; Nakada K; Hayashi KI; Osaka H; Abe T
    EBioMedicine; 2017 Jun; 20():27-38. PubMed ID: 28579242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson disease.
    Davis RL; Wong SL; Carling PJ; Payne T; Sue CM; Bandmann O
    Neurol Clin Pract; 2020 Feb; 10(1):40-46. PubMed ID: 32190419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of mitochondrial disorders.
    Shayota BJ
    Neurotherapeutics; 2024 Jan; 21(1):e00325. PubMed ID: 38295557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
    Kalko SG; Paco S; Jou C; Rodríguez MA; Meznaric M; Rogac M; Jekovec-Vrhovsek M; Sciacco M; Moggio M; Fagiolari G; De Paepe B; De Meirleir L; Ferrer I; Roig-Quilis M; Munell F; Montoya J; López-Gallardo E; Ruiz-Pesini E; Artuch R; Montero R; Torner F; Nascimento A; Ortez C; Colomer J; Jimenez-Mallebrera C
    BMC Genomics; 2014 Feb; 15():91. PubMed ID: 24484525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
    Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis.
    De Paepe B; Verhamme F; De Bleecker JL
    Cytokine; 2020 Mar; 127():154966. PubMed ID: 31901761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial disease.
    Koga Y; Povalko N; Inoue E; Nashiki K; Tanaka M
    Mitochondrion; 2019 Sep; 48():11-15. PubMed ID: 30738201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the Correlation between Growth Differentiation Factor 15 Serum Level and Its Gene Expression with Psoriasis and Its Severity.
    Akbari H; Talaee R; Zaker SF; Nikoueinejad H
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):593-599. PubMed ID: 34664818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection.
    Koga Y; Povalko N; Inoue E; Ishii A; Fujii K; Fujii T; Murayama K; Mogami Y; Hata I; Ikawa M; Fukami K; Fukumoto Y; Nomura M; Ichikawa K; Yoshida K
    J Inherit Metab Dis; 2021 Mar; 44(2):358-366. PubMed ID: 32965044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Utility of Circulating Growth Factors in Aortic Valve Stenosis: A Pilot Study.
    Hofmanis J; Tretjakovs P; Svirskis S; Gersone G; Hofmane D; Rozenberga U; Blumfelds L; Bahs G; Lejnieks A; Mackevics V
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33477548
    [No Abstract]   [Full Text] [Related]  

  • 35. Growth differentiation factor 15 is increased in stable MS.
    Amstad A; Coray M; Frick C; Barro C; Oechtering J; Amann M; Wischhusen J; Kappos L; Naegelin Y; Kuhle J; Mehling M
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 32024796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency.
    Motlagh Scholle L; Lehmann D; Joshi PR; Zierz S
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth Differentiation Factor-15 (GDF-15) is a potential marker of radiation response and radiation sensitivity.
    Sándor N; Schilling-Tóth B; Kis E; Benedek A; Lumniczky K; Sáfrány G; Hegyesi H
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():142-9. PubMed ID: 26520384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum biomarkers in primary mitochondrial disorders.
    Varhaug KN; Hikmat O; Nakkestad HL; Vedeler CA; Bindoff LA
    Brain Commun; 2021; 3(1):fcaa222. PubMed ID: 33501425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
    Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
    Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The divergent roles of growth differentiation factor-15 (GDF-15) in benign and malignant skin pathologies.
    Ünal B; Alan S; Başsorgun Cİ; Karakaş AA; Elpek GÖ; Çiftçioğlu MA
    Arch Dermatol Res; 2015 Sep; 307(7):551-7. PubMed ID: 25690161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.